Trade
Basic
Futures
Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
Trade global traditional assets with USDT in one place
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Earn
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and enjoy airdrop rewards!
Futures Points
Earn futures points and claim airdrop rewards
Investment
Simple Earn
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Soft Staking
Earn rewards with flexible staking
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-stop lending hub
VIP Wealth Hub
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Quant Fund
Top asset management team helps you profit without hassle
Staking
Stake cryptos to earn in PoS products
Smart Leverage
New
No forced liquidation before maturity, worry-free leveraged gains
GUSD Minting
Use USDT/USDC to mint GUSD for treasury-level yields
More
MarketMaestro
No content yet
MarketMaestro
$XLE $C
BUY Call 🤑 👇
BUY Call 🤑 👇
- Reward
- 1
- Comment
- Repost
- Share
$WDC
BULL's EYE!🎯
I said it could run all the way to the neckline that’s been in place since 1973. It got there. it can break that neckline and start writing a new story
BULL's EYE!🎯
I said it could run all the way to the neckline that’s been in place since 1973. It got there. it can break that neckline and start writing a new story
- Reward
- like
- Comment
- Repost
- Share
$RCL
This technical setup is risky. It couldn’t clear the fibo78 resistance, and a double top risk is on the table right now
This technical setup is risky. It couldn’t clear the fibo78 resistance, and a double top risk is on the table right now
- Reward
- like
- Comment
- Repost
- Share
$NNE
Honestly, they broke the indexes last week, right when the index had a chance to breakout, because of AI, Warsh, and other reasons. It also broke the green support.
There’s nothing below the OBZ it’s the last line of defense
Honestly, they broke the indexes last week, right when the index had a chance to breakout, because of AI, Warsh, and other reasons. It also broke the green support.
There’s nothing below the OBZ it’s the last line of defense
- Reward
- like
- Comment
- Repost
- Share
$SMR
The chart looks scary. If it breaks down below the green zone, It can become much riskier. In the prior bottoms I marked with the green box, it also created a similar risky look. Of course, back then the market was much calmer
The chart looks scary. If it breaks down below the green zone, It can become much riskier. In the prior bottoms I marked with the green box, it also created a similar risky look. Of course, back then the market was much calmer
- Reward
- like
- Comment
- Repost
- Share
- Reward
- like
- Comment
- Repost
- Share
$NBIS
Even showing this kind of strength at this stage is very good. But the danger isn’t over yet. The earliest we can start talking is if it clears red diagonal resistance
Even showing this kind of strength at this stage is very good. But the danger isn’t over yet. The earliest we can start talking is if it clears red diagonal resistance
- Reward
- like
- Comment
- Repost
- Share
$RDW
I was expecting this pullback, but I wasn’t expecting it to get this deep. When the market mood shifted from growth stocks to value stocks, the selloff intensified. Why? Because in this kind of environment, if the market doesn’t believe in the story for these cash burning names, it shows no mercy. This is a moonshot stock. It requires time, patience, and conviction
I was expecting this pullback, but I wasn’t expecting it to get this deep. When the market mood shifted from growth stocks to value stocks, the selloff intensified. Why? Because in this kind of environment, if the market doesn’t believe in the story for these cash burning names, it shows no mercy. This is a moonshot stock. It requires time, patience, and conviction
- Reward
- like
- Comment
- Repost
- Share
$MOVE
The anxiety isn’t in the $VIX. It’s in the MOVE. The bond vigilantes seem like they don’t want the Fed to cut rates. But if rates aren’t cut on time, the economy could slip into deflation. While the bond vigilantes are trying to keep the Fed’s hand cold, they’re ignoring the risk of pushing the economy into a deflation pit. And deflation is not a good thing at all. The vigilantes’ hawkish stance right now contradicts the fundamentals of the economy. Ignoring the disinflation process isn’t cooling the engine, it’s breaking it. If any vigilantes are reading this message, I’d love to give t
The anxiety isn’t in the $VIX. It’s in the MOVE. The bond vigilantes seem like they don’t want the Fed to cut rates. But if rates aren’t cut on time, the economy could slip into deflation. While the bond vigilantes are trying to keep the Fed’s hand cold, they’re ignoring the risk of pushing the economy into a deflation pit. And deflation is not a good thing at all. The vigilantes’ hawkish stance right now contradicts the fundamentals of the economy. Ignoring the disinflation process isn’t cooling the engine, it’s breaking it. If any vigilantes are reading this message, I’d love to give t
- Reward
- like
- Comment
- Repost
- Share
$SN
Such a hard to find setup in an environment like this!
Its financial growth is very strong. Based on the financials, this should still be ripping higher
Such a hard to find setup in an environment like this!
Its financial growth is very strong. Based on the financials, this should still be ripping higher
- Reward
- 1
- Comment
- Repost
- Share
There is no inflation in America! I’ve been trying to explain since I started writing here that the U.S. has entered a disinflation process. The market didn’t really take it positively, but…
- Reward
- like
- Comment
- Repost
- Share
$DKNG 👇❗️
View Original
- Reward
- like
- Comment
- Repost
- Share
$BGC
it did a neckline retest, then it also broke the red diagonal resistance and got stuck at the $9.60 fibo61 resistance. The monthly setup looks good
it did a neckline retest, then it also broke the red diagonal resistance and got stuck at the $9.60 fibo61 resistance. The monthly setup looks good
- Reward
- like
- Comment
- Repost
- Share
$META
It couldn’t clear $742-fibo78. That created a possible distribution setup risk. In 2021 the issue was fear of excessive CapEx spending. This time there isn’t the same fear because ad revenue is increasing; in 2021 it was seen as burying money in the grave.
At first, I think it will form a triangle like consolidation. But after the fibo78 rejection, I also can’t ignore the double top distribution pattern that’s showing up
It couldn’t clear $742-fibo78. That created a possible distribution setup risk. In 2021 the issue was fear of excessive CapEx spending. This time there isn’t the same fear because ad revenue is increasing; in 2021 it was seen as burying money in the grave.
At first, I think it will form a triangle like consolidation. But after the fibo78 rejection, I also can’t ignore the double top distribution pattern that’s showing up
- Reward
- like
- Comment
- Repost
- Share
$ANET
ANET Q4 2025 Financial Results and 2026 Outlook
Big picture: strong finish, more aggressive 2026 Arista Networks closed 2025 with a strong beat and shifted its 2026 message to a higher pace. In Q4 2025, the company reported $2.49B in revenue (+29% YoY) and $0.82 in Non-GAAP EPS. Combined with full-year 2025 growth of 28.6% and record revenue of $9B, this wasn’t just a strong quarter, it signals Arista is riding an expanding demand cycle.
2026 outlook: higher growth target, bar set at $11.25B Management translated confidence into numbers by raising its 2026 revenue growth target to 25% an
ANET Q4 2025 Financial Results and 2026 Outlook
Big picture: strong finish, more aggressive 2026 Arista Networks closed 2025 with a strong beat and shifted its 2026 message to a higher pace. In Q4 2025, the company reported $2.49B in revenue (+29% YoY) and $0.82 in Non-GAAP EPS. Combined with full-year 2025 growth of 28.6% and record revenue of $9B, this wasn’t just a strong quarter, it signals Arista is riding an expanding demand cycle.
2026 outlook: higher growth target, bar set at $11.25B Management translated confidence into numbers by raising its 2026 revenue growth target to 25% an
- Reward
- like
- Comment
- Repost
- Share
$ALAB
VWAP, EMA50, and BoS all broke key supports. The index is also below EMA21. Today’s CPI print is very important. Because if it can’t recover, the target becomes green zone. ALAB is like this: sharp corrections and sharp rallies
VWAP, EMA50, and BoS all broke key supports. The index is also below EMA21. Today’s CPI print is very important. Because if it can’t recover, the target becomes green zone. ALAB is like this: sharp corrections and sharp rallies
- Reward
- like
- Comment
- Repost
- Share
$NBIS
Nebius Group generated $227.7M in revenue in the final quarter of 2025, up 547% year over year, but it came in below the market expectation of $242.79M and the shares fell 3%. The company’s net loss widened versus the same quarter last year to $173M; however, Annual Recurring Revenue (ARR) came in at $1.25B, above the company’s own guidance. Management is maintaining its aggressive growth stance by targeting $7–$9B ARR and $3–$3.4B in revenue by the end of 2026. The company emphasized that its current GPU capacity is fully sold out for 2H 2025 and Q1 2026, with no slowdown in demand. It
Nebius Group generated $227.7M in revenue in the final quarter of 2025, up 547% year over year, but it came in below the market expectation of $242.79M and the shares fell 3%. The company’s net loss widened versus the same quarter last year to $173M; however, Annual Recurring Revenue (ARR) came in at $1.25B, above the company’s own guidance. Management is maintaining its aggressive growth stance by targeting $7–$9B ARR and $3–$3.4B in revenue by the end of 2026. The company emphasized that its current GPU capacity is fully sold out for 2H 2025 and Q1 2026, with no slowdown in demand. It
- Reward
- like
- Comment
- Repost
- Share
$SPY
OI-based Net Gamma Exposure: negative
Volume-based Net Gamma Exposure: clearly negative
Directionalized Volume: negative
This combination means a negative gamma regime. In a negative gamma regime, Market Makers are forced to trade in the direction of the price move. If the market falls, dealers SELL to hedge and accelerate the drop. If the market rises, dealers BUY to hedge, creating a squeeze.
There is a massive pile-up at the 680 strike level. We are currently at 681.06, meaning we are right on top of this big wall. The heavy open interest at this level acts like a magnet that pulls pri
OI-based Net Gamma Exposure: negative
Volume-based Net Gamma Exposure: clearly negative
Directionalized Volume: negative
This combination means a negative gamma regime. In a negative gamma regime, Market Makers are forced to trade in the direction of the price move. If the market falls, dealers SELL to hedge and accelerate the drop. If the market rises, dealers BUY to hedge, creating a squeeze.
There is a massive pile-up at the 680 strike level. We are currently at 681.06, meaning we are right on top of this big wall. The heavy open interest at this level acts like a magnet that pulls pri
- Reward
- like
- Comment
- Repost
- Share
Today's ERs
$RCAT
$RCAT
- Reward
- like
- Comment
- Repost
- Share
$HIMS
The wind has turned against HIMS. Compounded GLP-1 products, which sit at the center of the company’s growth story, are no longer just a gray-area debate, they are now facing a concrete regulatory barrier. Especially with the FDA hardening its tone and bringing the Department of Justice (DoJ) into the process, the risk parameters have completely changed.
Novo Nordisk’s legal moves, and especially the fact that oral formulations are being treated as a red line, have increased the pressure on the company. The fact that HIMS had to stop oral GLP-1 sales is also operational proof of this pre
The wind has turned against HIMS. Compounded GLP-1 products, which sit at the center of the company’s growth story, are no longer just a gray-area debate, they are now facing a concrete regulatory barrier. Especially with the FDA hardening its tone and bringing the Department of Justice (DoJ) into the process, the risk parameters have completely changed.
Novo Nordisk’s legal moves, and especially the fact that oral formulations are being treated as a red line, have increased the pressure on the company. The fact that HIMS had to stop oral GLP-1 sales is also operational proof of this pre
- Reward
- like
- Comment
- Repost
- Share
